Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II–III gliomas to establish genetic predictors of poor prognosis.

MLA

Kuwahara, Kiyonori, et al. “Clinical, Histopathological, and Molecular Analyses of IDH-Wild-Type WHO Grade II–III Gliomas to Establish Genetic Predictors of Poor Prognosis.” Brain Tumor Pathology, vol. 36, no. 4, Oct. 2019, pp. 135–43. EBSCOhost, https://doi.org/10.1007/s10014-019-00348-9.

APA

Kuwahara, K., Ohba, S., Nakae, S., Hattori, N., Pareira, E. S., Yamada, S., Sasaki, H., Abe, M., Hasegawa, M., & Hirose, Y. (2019). Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II–III gliomas to establish genetic predictors of poor prognosis. Brain Tumor Pathology, 36(4), 135–143. https://doi.org/10.1007/s10014-019-00348-9

Chicago

Kuwahara, Kiyonori, Shigeo Ohba, Shunsuke Nakae, Natsuki Hattori, Eriel Sandika Pareira, Seiji Yamada, Hikaru Sasaki, Masato Abe, Mitsuhiro Hasegawa, and Yuichi Hirose. 2019. “Clinical, Histopathological, and Molecular Analyses of IDH-Wild-Type WHO Grade II–III Gliomas to Establish Genetic Predictors of Poor Prognosis.” Brain Tumor Pathology 36 (4): 135–43. doi:10.1007/s10014-019-00348-9.